Follow-The-Filings

AVBP · Arrivent Biopharma Inc.

Q2 2024 13F holders

← latest ownership dossier

Ticker
AVBP
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares